Study Projects Dramatic Increase in ALS Prevalence by 2040
A new study projects that global ALS prevalence will rise by about 25% by 2040—driven largely by an aging population and improved survival.
Category: ALS
ALS
Latest
ALS
Latest
Permobil Foundation Gifts Power Wheelchair to Disability Advocate with ALS
The Permobil Foundation gave Osiel Mendoza his own San Francisco Giants-branded, custom Permobil power wheelchair as part of the Lou Gehrig celebrations.
ALS
Latest
TeamALS Raises Funds, Increases Awareness During Chicago Marathon
TeamALS raised over $380,000 in support of individuals battling ALS at the Chicago Marathon, held Sunday, October 9.
EverythingALS and Partners Initiate The Radcliff Study
EverythingALS initiates a new study, The Radcliff Study, with partners in the quest to find a diagnosis, treatment, and cure for ALS.
Read More
ALS Risk Higher Among Production Workers, Those Exposed to Metals, Volatile Compounds on the Job
Those working in production who are exposed to hazardous chemicals on the job may have increased risk of developing ALS, a study suggests.
Read More
Stem Cell and Gene Therapy Shows Promise in ALS Safety Trial
Cedars-Sinai investigators confirm the safety of a novel stem cell and gene therapy targeting motor neurons that die in patients with ALS.
Read More
New Blood Test for ALS Promises Rapid Diagnosis
The genetic fingerprint of five microRNA sequences in blood samples accurately discriminated between people with ALS and healthy individuals.
Read More
Research Provides New Insight into ALS
Apolipoprotein B-100 is an agent responsible for causing permanent motor disability, motor neuron degeneration, and other pathology in ALS.
Read More
Patients with ALS Are Not Only Troubled by Muscle Weakness and Respiratory Dysfunction
Non-motor symptoms such as pain, fatigue, and sleep disorders, are observed in patients with ALS and reduce their quality of life.
Read More
Gene Therapy Approach Shows Promise in Treating ALS
A gene therapy approach, developed at UC San Diego, measurably delayed disease onset in humanized mouse and rat models of familial ALS.
Read More
NeuroSense Joins EverythingALS Open Innovation Consortium
EverythingALS announces NeuroSense Therapeutics Ltd as a new collaborator in the effort to identify treatments and a cure for ALS.
Read More
NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers Using AI and ML
NeuroSense and NeuraLight collaborate to advance the science of digital biomarkers in the detection and monitoring of ALS.
Read More
NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study
New Stage III biomarker data in people with ALS validates NeuroSense’s clinical strategy, the company reports.
Read More
ALS May Be Linked to Both the Immune and Central Nervous Systems
The immune system may play a fundamental role along with the central nervous system in ALS, Mount Sinai researchers report.
Read More
Muscle Biopsy Test for Biomarker Could Lead to Earlier Diagnosis of ALS
In JAMA Neurology, researchers outline preliminary research that could pave the way for a future test for earlier diagnosis of ALS.
Read More
Relationship Between ALS Disease Patterns, Microscopic Changes in Brain, Spinal Cord Identified
Researchers have identified a relationship between the patterns of ALS symptoms and microscopic changes in the brain and spinal cord.
Read More
Stealth BioTherapeutics Presents ALS Therapy Data at Keystone Neurodegeneration Symposium
Stealth BioTherapeutics Corp presents SBT-272 preclinical data demonstrating improvement in upper neuron function in ALS.
Read More
Muscular Dystrophy Association Celebrates Lou Gehrig Day at Major League Baseball Games in June
The Muscular Dystrophy Association will honor Major League Baseball’s recognition of Lou Gehrig Day at games across the country in June.
Read More